Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

Nanexa AB announces today that the first patient has been dosed in the 30 mg dose group in the ongoing Phase I study with NEX-22, the company's one-month formulation of liraglutide. The ongoing Phase ...

In the 13-week study, minimal focal inflammatory cell infiltration in the exocrine pancreas was seen in one control female and one high-dose liraglutide male (of six monkeys at each dose level and ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to ... of all new prescriptions were for it. Tirzepatide, Liraglutide, and Semaglutide are the only three GLP ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...

The vibes are shifting on Wall Street. Popular gauges of investor sentiment are showing that the pervasive sense of optimism that followed President Donald Trump’s election victory in November ...

It comes after the FDA said the drug’s shortage is over ... Instead, its weight-loss program will now focus on oral-based solutions and liraglutide (Saxenda), which is also a Novo product. "We see our ...

Since, the patent for the diabetes drug Liraglutide has expired CTT will seek to find opportunities to utilize our micelle technology for Liraglutide. CTT also believes our technology could offer ...

Analysts at Citi said Hims & Hers' goal of $725 million of weight-loss revenue in 2025 was ambitious, given oral-drug sales just reached $100 million annualized in July and liraglutide requires ...

Mounjaro, Ozempic, Rybelsus, Wegovy and Victoza are all drugs that can be ... any unwanted side effects – also known as an adverse drug reaction – they’ve had after using a medicine.